Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Neurology
.
2024 May 14;102(9):e209377.
doi: 10.1212/WNL.0000000000209377.
Epub 2024 Apr 22.
Authors
Maria Vassilaki
1
,
Rioghna R Pittock
2
,
Jeremiah A Aakre
1
,
Anna M Castillo
1
,
Vijay K Ramanan
1
,
Walter K Kremers
1
,
Clifford R Jack Jr
1
,
Prashanthi Vemuri
1
,
Val J Lowe
1
,
David S Knopman
1
,
Ronald C Petersen
1
,
Jonathan Graff-Radford
1
Affiliations
1
(Rochester, MN).
2
(Chicago, IL).
PMID:
38648608
DOI:
10.1212/WNL.0000000000209377
No abstract available
Publication types
Letter
MeSH terms
Alzheimer Disease / drug therapy
Amyloid beta-Peptides
Cognitive Aging*
Humans
Substances
Amyloid beta-Peptides